ZEISS Medical Technology’s CLARUS® 700 has officially received approval from China’s National Medical Products Administration (NMPA), marking a significant milestone in the availability of advanced retinal imaging solutions in the country. The CLARUS 700 offers a combination of ultra-widefield fundus imaging, True Color visualization, and Fluorescein Angiography (FA), delivering unmatched clarity and comprehensive retinal assessment. This innovation supports eye care professionals in accurately diagnosing and monitoring a wide range of retinal diseases, including diabetic retinopathy and age-related macular degeneration.

The system captures up to 133° in a single image and expands to 267° with multiple images, providing detailed coverage from the macula to the far periphery. Features like PrecisionFocus, AutoBright, and QuickCompare enhance workflow efficiency by enabling quick image adjustments and comparisons across patient visits. Clinicians also benefit from live infrared imaging and AI-enhanced capture, which contribute to improved visualization of retinal structures. These capabilities are crucial for high-volume clinics aiming to streamline diagnostic accuracy while maximizing patient throughput.

The NMPA approval brings one of ZEISS’s most advanced diagnostic tools to Chinese ophthalmologists, enhancing their ability to preserve vision through earlier and more precise intervention. As retinal conditions continue to rise with an aging population, tools like the CLARUS 700 are vital for supporting proactive and high-quality eye care. This launch not only strengthens ZEISS’s footprint in the Chinese market but also reflects its continued commitment to equipping specialists with transformative technologies that elevate diagnostic standards globally.

MedTech Spectrum's Summary

Advanced Retinal Imaging Approved in China: ZEISS CLARUS 700 has received NMPA approval, bringing ultra-widefield, True Color, and high-resolution fluorescein angiography to Chinese ophthalmologists.

Enhanced Diagnostic Precision: The system’s integration of AI-enhanced capture, PrecisionFocus, and QuickCompare significantly improves clinical workflow and supports accurate diagnosis of complex retinal diseases.

Strengthening Vision Care Infrastructure: With its cutting-edge capabilities, the CLARUS 700 will empower eye care professionals across China to deliver earlier interventions and better visual outcomes, reinforcing ZEISS’s role in advancing global eye health.